INDRACCOLO, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.693
AS - Asia 11.238
EU - Europa 5.026
AF - Africa 1.883
SA - Sud America 1.710
OC - Oceania 171
Continente sconosciuto - Info sul continente non disponibili 81
Totale 38.802
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.717
SG - Singapore 3.371
CN - Cina 2.015
VN - Vietnam 1.896
HK - Hong Kong 1.145
BR - Brasile 1.006
IT - Italia 962
DE - Germania 556
FI - Finlandia 461
FR - Francia 410
IN - India 336
BD - Bangladesh 329
GB - Regno Unito 269
SE - Svezia 251
PL - Polonia 244
RU - Federazione Russa 182
IQ - Iraq 177
NL - Olanda 174
UA - Ucraina 160
AR - Argentina 145
CA - Canada 145
JP - Giappone 128
TR - Turchia 127
SA - Arabia Saudita 106
ZA - Sudafrica 106
CI - Costa d'Avorio 100
PH - Filippine 100
PK - Pakistan 97
KR - Corea 96
ID - Indonesia 95
EC - Ecuador 93
ES - Italia 92
AT - Austria 91
MX - Messico 88
BJ - Benin 85
VE - Venezuela 82
IE - Irlanda 79
CO - Colombia 74
MY - Malesia 73
UZ - Uzbekistan 72
AZ - Azerbaigian 68
CL - Cile 68
IL - Israele 67
EG - Egitto 63
KE - Kenya 63
MA - Marocco 63
AE - Emirati Arabi Uniti 62
DZ - Algeria 62
TN - Tunisia 62
ET - Etiopia 60
JO - Giordania 60
JM - Giamaica 59
AO - Angola 58
NP - Nepal 58
AL - Albania 57
CH - Svizzera 54
KG - Kirghizistan 54
PS - Palestinian Territory 54
PE - Perù 53
DK - Danimarca 52
GA - Gabon 52
GH - Ghana 50
PR - Porto Rico 50
GR - Grecia 49
HU - Ungheria 49
MR - Mauritania 49
BA - Bosnia-Erzegovina 48
BO - Bolivia 48
GT - Guatemala 48
KH - Cambogia 48
PT - Portogallo 48
PY - Paraguay 48
TT - Trinidad e Tobago 48
CR - Costa Rica 47
CY - Cipro 47
HR - Croazia 47
UY - Uruguay 47
BF - Burkina Faso 46
EE - Estonia 46
LB - Libano 46
SO - Somalia 46
TJ - Tagikistan 46
CZ - Repubblica Ceca 45
ML - Mali 45
NO - Norvegia 45
RS - Serbia 45
BG - Bulgaria 44
BS - Bahamas 44
NZ - Nuova Zelanda 44
TH - Thailandia 44
YT - Mayotte 44
CW - ???statistics.table.value.countryCode.CW??? 43
HN - Honduras 43
TW - Taiwan 43
GE - Georgia 42
LC - Santa Lucia 42
PA - Panama 42
RO - Romania 42
SK - Slovacchia (Repubblica Slovacca) 42
BE - Belgio 41
Totale 36.765
Salva come PNG Salva come JPEG
Città #
Ashburn 2.565
Singapore 2.080
Fairfield 1.906
San Jose 1.757
Woodbridge 1.241
Chandler 1.060
Hong Kong 1.039
Houston 973
Ann Arbor 775
Cambridge 704
Seattle 683
Ho Chi Minh City 589
Wilmington 581
Hanoi 457
Beijing 419
Santa Clara 376
Jacksonville 354
Los Angeles 319
Helsinki 264
Boardman 248
San Diego 248
Princeton 235
New York 224
Munich 203
Lauterbourg 172
Padova 165
Bytom 142
Da Nang 120
Des Moines 120
Chicago 119
Medford 114
São Paulo 106
Abidjan 99
Hefei 94
Milan 94
Buffalo 89
Orem 86
Roxbury 86
Nanjing 83
Cotonou 81
Tokyo 79
Haiphong 77
Guangzhou 75
Council Bluffs 74
Baghdad 71
Seoul 66
Baku 64
Warsaw 64
London 63
Tashkent 62
Dublin 60
Frankfurt am Main 60
Amman 55
Nuremberg 55
Johannesburg 51
Nairobi 50
Dong Ket 49
Libreville 49
Montreal 49
Chennai 48
Addis Ababa 47
Bishkek 47
Rome 47
Luanda 46
Nouakchott 46
Phnom Penh 45
Shanghai 45
Turku 45
Dushanbe 44
Vienna 43
Amsterdam 42
Castries 42
Kingston 42
Nassau 42
Denver 41
Bamako 40
Accra 39
Dakar 39
Dallas 39
Stockholm 38
Ulan Bator 38
Brooklyn 37
Montevideo 37
Djibouti 36
Lusaka 36
Niamey 36
Panama City 36
Riyadh 36
Conakry 35
Kuala Lumpur 35
Phoenix 35
San José 35
The Dalles 35
Harare 34
Jeddah 34
Riga 34
Tallinn 34
Antananarivo 33
Cayenne 33
Atlanta 32
Totale 23.851
Salva come PNG Salva come JPEG
Nome #
Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1 452
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis 367
Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors 318
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma. 318
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells 317
Genetic, epigenetic and immunologic profiling of MMR-deficient relapsed glioblastoma 314
Platelet-Derived Growth Factor-D Enables Liver Myofibroblasts to Promote Tumor Lymphangiogenesis in Cholangiocarcinoma 299
SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia 298
Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer 297
A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model 296
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 296
Analysis of Epstein-Barr virus (EBV) type and variant in spontaneous lymphoblastoid cells and Hu-SCID mouse tumours 293
Gene therapy of ovarian cancer with IFN-α-producing fibroblasts: Comparison of constitutive and inducible vectors 292
NOTCH3 SIGNALING REGULATES MUSASHI-1 EXPRESSION IN METASTATIC COLORECTAL CANCER CELLS. 284
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer 282
Interferon-α gene therapy by lentiviral vectors contrasts ovarian cancer growth through angiogenesis inhibition 281
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study 281
Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus 280
28P Different genetic profiling in lung adenocarcinoma of smokers with and without chronic obstructive pulmonary disease (COPD): An exploratory analysis by next generation sequencing (NGS) 280
An immediate transcriptional signature associated with response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts 276
Selective killing of human T-ALL cells: an integrated approach targeting redox homeostasis and the OMA1/OPA1 axis 274
Reconstruction of gene regulatory modules from RNA silencing of IFN-α modulators: Experimental set-up and inference method 273
LKB1 expression correlates with increased survival in advanced non-small cell lung cancer patients treated with chemotherapy and bevacizumab 272
Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia 268
Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells 267
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 264
Establishment and characterization of xenografts and cancer cell cultures derived from BRCA1 -/- epithelial ovarian cancers 264
MODULATION OF MICRORNA EXPRESSION IN HUMAN T CELL DEVELOPMENT: TARGETING OF NOTCH3 BY MIR-150 263
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 263
166P: Non-small cell lung cancer (NSCLC) patients with rare or complex epidermal growth factor receptor (EGFR) mutations: A single institution series 262
Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman 261
Calcineurin and GSK-3 inhibition sensitizes T-cell acute lymphoblastic leukemia cells to apoptosis through X-linked inhibitor of apoptosis protein degradation 260
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells 260
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations 259
Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer 257
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 257
Rewiring of Lipid Metabolism and Storage in Ovarian Cancer Cells after Anti-VEGF Therapy 256
Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization. 254
Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells 254
ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia 253
LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and γ-irradiation 253
Low dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 249
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. 249
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 248
Notch3 signalling promotes tumour growth in colorectal cancer 248
hTERT Inhibition Triggers Epstein-Barr Virus Lytic Cycle and Apoptosis in Immortalized and Transformed B Cells: A Basis for New Therapies. 247
Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts. 246
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW) 245
Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts 245
Glycolytic Phenotype and AMP Kinase Modify the Pathologic Response of Tumor Xenografts to VEGF Neutralization 244
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective 244
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 243
A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib 242
A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia 239
Comparison of the genomic profile of cancer stem cells and their non-stem counterpart: The case of ovarian cancer 239
Angiogenesis meets immunology: Cytokine gene therapy of cancer 237
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study 237
EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience 236
Chemokine receptor expression in EBV-associated lymphoproliferation in hu/SCID mice: implications for CXCL12/CXCR4 axis in lymphoma generation 235
Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab. 234
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines 229
DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice. 228
Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis 225
Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation. 225
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors 223
Assessment of therapeutic effects of Notch-1 blockade in T-acute lymphoblastic leukemia xenograft models 222
Genetic perturbation of IFN-α transcriptional modulators in human endothelial cells uncovers pivotal regulators of angiogenesis 221
A Cd3(+)cd8(+) T-cell Population Lacking Cd5 Antigen Expression Is Expanded In Peripheral-blood of Human Immunodeficiency Virus-infected Patients 220
Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257) 218
Involvement of NADPH Oxidase 1 in Liver Kinase B1-mediated effects on tumor angiogenesis and growth 218
In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach 218
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg? 216
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 216
Implementation of next generation sequencing-based liquid biopsy for clinical molecular diagnostics in non-small cell lung cancer (Nsclc) patients 216
Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts 215
DOMINANCE OF A SINGLE EPSTEIN-BARR-VIRUS STRAIN IN SCID-MOUSE TUMORS INDUCED BY INJECTION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HEALTHY-HUMAN DONORS 214
M30 Neoepitope Expression in Epithelial Cancer: Quantification of Apoptosis in Circulating Tumor Cells by CellSearch Analysis 214
A multi-center, real-life experience on liquid biopsy practice for EGFR testing in non-small cell lung cancer (NSCLC) patients 214
Recruitment of human umbilical vein endothelial cells and human primary fibroblasts into experimental tumors growing in SCID mice 213
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features 213
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 211
Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer 209
CD40 activation of B-CLL cells is associated with augmented intracellular levels of CD79b and increased BCR expression in a subset of patients 207
Therapeutic potential of the phosphino Cu(I) complex (HydroCuP) in the treatment of solid tumors 204
Phosphorylated acetyl-coa carboxylase is associated with clinical benefit with regorafenib in relapsed glioblastoma: REGOMA trial biomarker analysis 204
Is There a Link between Chronic Obstructive Pulmonary Disease and Lung Adenocarcinoma? A Clinico-Pathological and Molecular Study 203
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 203
Dormant tumors awaken by a short-term angiogenic burst - The spike hypothesis 202
hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: Implications for EBV-driven lymphomagenesis 201
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome 201
Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinoma. 200
Interferon-alpha counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancer 200
Aspirin-triggered DHA metabolites inhibit angiogenesis 199
Metformin: a modulator of bevacizumab activity in cancer? A case report. 199
Potentialities of liquid biopsy in advanced non-small cell lung cancer (aNSCLC): Early evaluation of sentinel mutations in plasma and outcome of patients treated with immunotherapy 199
Precision medicine in cholangiocarcinoma 198
Alternatively spliced forms of Ig alpha and Ig beta prevent B cell receptor expression on the cell surface 197
Genetic perturbation of pyruvate dehydrogenase kinase 1 modulates growth, angiogenesis and metabolic pathways in ovarian cancer xenografts 197
P118 IFN-A transcriptional response in endothelial cells: Key modulators and gene regulatory modules 196
Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. 196
Totale 24.626
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.095
article - articoli 103.927
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 492
Totale 213.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021400 0 0 0 0 0 0 0 0 0 0 209 191
2021/20222.761 110 297 295 130 141 206 422 215 94 76 293 482
2022/20231.969 385 255 63 296 247 246 12 120 228 18 82 17
2023/20241.244 45 176 128 102 122 196 95 64 61 49 100 106
2024/20254.828 18 276 273 175 581 172 217 468 476 163 797 1.212
2025/202620.740 963 1.592 2.656 3.363 1.731 912 3.366 1.744 2.332 1.123 958 0
Totale 38.990